US Edition
Published • loading... • Updated
Surfactant Therapy in Preterm Infants with Heart Disease
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Surfactant Therapy in Preterm Infants with Heart Disease
In the intricate and high-stakes world of neonatal intensive care, managing premature infants with congenital heart disease (CHD) presents unique and daunting challenges. Among these, the decision to administer surfactant replacement therapy (SRT) stands as one of the most nuanced and critical interventions. Surfactant therapy, a well-established treatment to address respiratory distress syndrome (RDS) in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
